Type of diabetes-Type 2 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

What is the effect of weight-loss surgery on psychological health in patients with type 2 diabetes and obesity?

What is the effect of weight-loss surgery on psychological health in patients with type 2 diabetes and obesity?

Posted by on Aug 27, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the psychological impact of Roux-en-Y gastric bypass with silastic ring (SR-RYGB) or sleeve gastrectomy (SG) in patients with type 2 diabetes (T2D) and obesity and associations with improved symptoms of depression and quality of life (QoL). The study showed that both types of bariatric (weight-loss) surgery were...

Read More

Can new glucose-lowering medications influence stroke risk in patients with type 2 diabetes?

Can new glucose-lowering medications influence stroke risk in patients with type 2 diabetes?

Posted by on Jun 11, 2023 in Diabetes mellitus | 0 comments

In a nutshell This review assessed the effects of new glucose-lowering drugs on stroke risk in patients with type 2 diabetes (T2D). The study showed that glucagon-like peptide-1 receptor (GLP-1) agonists are potentially beneficial for stroke risk in patients with T2D. Some background Patients with diabetes are at a higher risk of developing...

Read More

How safe and effective is orally delivered insulin for patients with early-stage type 2 diabetes?

How safe and effective is orally delivered insulin for patients with early-stage type 2 diabetes?

Posted by on Apr 15, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and effectiveness of different doses of an oral insulin capsule formulation (Capsulin™) to patients with early-stage type 2 diabetes (T2D). The data showed that twice-daily, orally administered Capsulin at a dose of 150 international units (IU) was safe and resulted in a significant lowering...

Read More

How can counselling affect pancreatic beta-cell function in patients with type 2 diabetes?

How can counselling affect pancreatic beta-cell function in patients with type 2 diabetes?

Posted by on Mar 26, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study analyzed the long-term effect of behavioral counseling on increasing daily physical activity (PA) and reducing sedentary (SED) time on changes in beta-cell (β-cell) function and glucose control in patients with type 2 diabetes (T2D). The authors concluded that increasing moderate-to-vigorous-intensity physical activity...

Read More

Do some anti-diabetic medications affect the risk of fractures in patients with type 2 diabetes?

Do some anti-diabetic medications affect the risk of fractures in patients with type 2 diabetes?

Posted by on Feb 19, 2023 in Diabetes mellitus | 0 comments

In a nutshell This analysis investigated the relationship between anti-diabetic medications and the risk of fractures in patients with type 2 diabetes (T2D). The data showed that glucagon-like peptide-1 receptor agonists (GLP1-RAs) and sulfonylurea (SU) provided better protection against fractures compared to thiazolidinedione (TZD) or dipeptidyl...

Read More

Evaluating the effects of the plant-based polyphenol-rich extract TOTUM-63 on glucose control in patients with prediabetes or early-stage type 2 diabetes.

Evaluating the effects of the plant-based polyphenol-rich extract TOTUM-63 on glucose control in patients with prediabetes or early-stage type 2 diabetes.

Posted by on Feb 5, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effects of the plant-based polyphenol-rich extract TOTUM-63 on glucose control in patients with prediabetes or early-stage newly diagnosed type 2 diabetes (T2D). The data showed that TOTUM-63 was safe and lowered fasting blood glucose in these patients.  Some background Patients with...

Read More

Is dorzagliatin an effective add-on treatment to metformin in patients with type 2 diabetes?

Is dorzagliatin an effective add-on treatment to metformin in patients with type 2 diabetes?

Posted by on Nov 5, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of adding dorzagliatin (HMS552) to metformin therapy in patients with type 2 diabetes (T2D) with inadequately controlled blood glucose (sugar) while using metformin (Glucophage) alone. The data showed effective blood glucose control, good tolerance, and safety in patients...

Read More

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of teneligliptin (Tenelia) to placebo in patients with type 2 diabetes (T2D) that was inadequately controlled with triple oral antidiabetic drugs (OADs). The study showed that teneligliptin may be considered as a fourth add-on OAD treatment in these patients. Some background T2D is...

Read More

Can physical activity affect glucose levels variations in patients with diabetes?

Can physical activity affect glucose levels variations in patients with diabetes?

Posted by on Feb 13, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effect of physical activity interventions on glycemic variability (GV; glucose levels variations) in patients with diabetes. The data showed that physical activity was associated with significantly reduced GV in these patients. Some background Physical activity has been shown to reduce hemoglobin A1c (the...

Read More

How beneficial is sodium-glucose co-transporter 2 inhibitor treatment for patients with type 2 diabetes mellitus and heart failure?

How beneficial is sodium-glucose co-transporter 2 inhibitor treatment for patients with type 2 diabetes mellitus and heart failure?

Posted by on Jan 20, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed the long-term use of sodium-glucose co-transporter 2 inhibitors (SGLT-2i) on the risk of mortality and hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) and heart failure (HF). The authors concluded that long-term use of SGLT-2 inhibitors can help to reduce mortality risk and HHF in...

Read More